J&J, FDA Share Blame On Motrin "Phantom Recall"
FDA's Sharfstein says agency "could've done better" in asking questions after it was contacted by J&J about problems with Motrin.
FDA's Sharfstein says agency "could've done better" in asking questions after it was contacted by J&J about problems with Motrin.